Ausgabe 3/1997
Inhalt (7 Artikel)
ORIGINAL ARTICLE
Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104
Alessandra Cesano, Sophie Visonneau, John H. Wolfe, K. Ann Jeglum, Jose Fernandez, Alfred Gillio, Richard J. O’Reilly, D. Santoli
ORIGINAL ARTICLE
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma
John M. Kirkwood, John Wilson, Theresa L. Whiteside, Sandra Donnelly, Ronald B. Herberman
ORIGINAL ARTICLE
Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients
Sonja Fischer, Armin Scheffler, D. Kabelitz
ORIGINAL ARTICLE
Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma
P. Wersäll, I. Ohlsson, P. Biberfeld, V. P. Collins, S. von Krusenstjerna, S. Larsson, H. Mellstedt, J. Boethius
ORIGINAL ARTICLE
Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages
S. T. Dougherty, Connie J. Eaves, William H. McBride, Graeme J. Dougherty
ORIGINAL ARTICLE
Postural effects on peritoneal transport and systemic uptake of radiolabeled monoclonal antibodies
Jeffrey S. Barrett, Susan J. Fisher, R. L. Wahl
ORIGINAL ARTICLE
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
Robert M. Sharkey, Thomas M. Behr, M. Jules Mattes, Rhona Stein, Gary L. Griffiths, Lisa B. Shih, Hans J. Hansen, Rosalyn D. Blumenthal, Robert M. Dunn, Malik E. Juweid, D. M. Goldenberg